Cornell University for the Joan & Sanford I. Weill Medical College of Cornell University
Date of Award
Crohn's Disease, Therapeutics
Term of Grant
Targeting the mycobiome in Crohn’s Disease: development of targeting strategy and biomarkers for prospective clinical trial
This study will identify Crohn’s disease-specific fungal strains and provide insight into their interactions with the immune system and how they contribute to disease development and progression. This could further lead to the identification of Crohn’s disease patients who would benefit from existing anti-fungal medications and development of new therapeutics targeting disease-causing fungi.